Bo Kruse - Jan 4, 2022 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
EVP, CFO, Secretary & Treas.
Signature
/s/ Bo Kruse
Stock symbol
YMAB
Transactions as of
Jan 4, 2022
Transactions value $
-$68,480
Form type
4
Date filed
1/5/2022, 04:15 PM
Previous filing
Dec 23, 2021
Next filing
Jan 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Sale -$68.5K -4K -2.03% $17.12 193K Jan 4, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2021.